Ayala Pharmaceuticals RSI
What is the RSI of Ayala Pharmaceuticals?
The RSI of Ayala Pharmaceuticals Inc. is 32.00
What is the definition of RSI?
The relative strength index (RSI 14) is a momentum indicator that compares the magnitude of gains and losses over a specified time period to measure speed and change of price movements of a security.
14-day period
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI of companies in the Health Care sector on NASDAQ compared to Ayala Pharmaceuticals
What does Ayala Pharmaceuticals do?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Companies with rsi similar to Ayala Pharmaceuticals
- CSOP ETF SERIES - CSOP Hong Kong Dollar Money Market ETF has RSI of 31.99
- Cemtrex has RSI of 31.99
- Magnetic Resources NL has RSI of 31.99
- Trigano SA has RSI of 31.99
- Elfato has RSI of 31.99
- H&R GmbH & Co. KGaA has RSI of 31.99
- Ayala Pharmaceuticals has RSI of 32.00
- Chakana Copper has RSI of 32.01
- Distil plc has RSI of 32.01
- Sunway International has RSI of 32.01
- Royal Century Resources has RSI of 32.01
- Xtrackers - MSCI Korea UCITS ETF has RSI of 32.01
- Weatherford International plc has RSI of 32.02